Skip to content
Tenfell
Awarded contract
Published 22 Apr 2025

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

NHS England · London

Key facts

Awarded
24 Mar 2025
Contract starts
30 Apr 2025
Contract ends
30 Apr 2029
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 50 suppliers

SupplierValue
Baxter Healthcare Ltd—
Takeda UK Limited—
Celix Pharma Ltd.—
Colonis Pharma Ltd—
CST Pharma Ltd—
Gerot Lannach UK Ltd—
Janssen-Cilag Ltd—
Orifarm UK—
Pfizer Ltd—
Teva UK Ltd—
Bayer plc—
Abbvie Ltd—
Aventis Pharma Ltd T/A Sanofi—
Grunenthal Ltd—
Napp Pharmaceuticals—
Sandoz Ltd—
Selective Supplies Ltd—
Thornton & Ross Ltd—
Wockhardt UK Limited—
Accord-UK Ltd—
Gedeon Richter UK Ltd—
Ipsen—
Merck Serono Limited—
Mylan—
Neon Healthcare Ltd—
Novartis Pharmaceuticals UK Ltd—
Novo Nordisk—
Organon Pharmaceuticals UK Ltd—
Sun Pharma UK Ltd—
Zentiva Pharma UK Ltd—
Day Lewis Medical Ltd—
Drugsrus Ltd—
medac Pharma LLP—
Neuraxpharm UK Ltd—
Strandhaven Ltd t/a Somex Pharma—
Tillomed Laboratories ltd—
FLYNN PHARMA LTD—
Glenmark Pharmaceuticals Europe Ltd—
Intrapharm Laboratories Ltd—
Aspire Pharma Ltd—
Ferring Pharmaceuticals Limited—
Galen Ltd—
Norgine Pharmaceuticals Limited—
Lupin Healthcare UK Ltd—
Mercury Pharmaceuticals Limited—
Otsuka Pharmaceuticals (UK) Ltd—
Merz—
Dexcel Pharma Ltd—
CSL Behring UK Ltd—
Aspen Pharmacare UK Limited—

Description

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025 Offer reference number: CM/PHR/22/5683 NHS Framework Agreement for Branded Medicines - Proprietary Category Tender: Period of Framework Agreement: 01 May 2025 to 30 April 2029

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.